| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 378 | 163 |
| Effect of exchange rate changes on cash and cash equivalents | 357 | 299 |
| Net decrease in cash and cash equivalents | -40,387 | -37,600 |
| Cash and cash equivalents at beginning of period | 78,232 | - |
| Cash and cash equivalents at end of period | 37,845 | - |
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)